CDC Backs Full Approval of Moderna COVID Vaccine
FRIDAY, Feb. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Friday gave its full approval to Moderna's COVID-19 vaccine for use in people 18 and older.
This follows a similar move made Jan. 31 by its sister agency, the U.S. Food and Drug Administration.
The vaccine, which had before been available for that age group only under emergency use authorization (EUA), will be marketed as Spikevax. It's not yet fully approved or authorized for use in people younger than 18.
Full Article